NCT05957159View on ClinicalTrials.gov

Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

August 1, 2028

Study Completion Date

November 1, 2028

Conditions
Alcohol Use Disorder
Interventions
OTHER

Detoxification Program

Patients will begin inpatient or outpatient detoxification prior to completing imaging

RADIATION

PKAB

90 PET Imaging Scan using \[11C\]LY2795050 (AKA \[11C\]PKAB)

RADIATION

CFN

90 Pet Imaging Scan using \[11C\]-Carfentanil

Trial Locations (1)

06519

RECRUITING

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER